⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XAIR News
Beyond Air, Inc. Common Stock
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended September 30, 2026
globenewswire.com
XAIR
Form 8-K
sec.gov
XAIR
Beyond Air® Preannounces Preliminary Revenue for the Quarter Ended September 30, 2026
globenewswire.com
XAIR
Form 8-K
sec.gov
XAIR
Broward Families to Receive Free Hurricane Supplies During Peak Hurricane Season
accessnewswire.com
XAIR
Beyond Air to Participate in the 2026 Cantor Global Healthcare Conference
globenewswire.com
XAIR
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
globenewswire.com
XAIR
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments
globenewswire.com
XAIR
Form 8-K
sec.gov
XAIR
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
globenewswire.com
XAIR